Published in Semin Oncol on August 01, 2008
Advances in molecular genetics and treatment of core-binding factor acute myeloid leukemia. Curr Opin Oncol (2008) 1.14
High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations. Blood (2012) 1.09
Systems biology of human benzene exposure. Chem Biol Interact (2009) 0.99
Treatment of acute myeloid leukemia. Haematologica (2009) 0.94
Allogeneic stem cell transplantation in first complete remission. Curr Opin Hematol (2011) 0.85
Next generation sequencing of acute myeloid leukemia: influencing prognosis. BMC Genomics (2015) 0.80
Impact of residual normal metaphases in core binding factor acute myeloid leukemia. Cancer (2011) 0.78
Clathrin assembly protein CALM plays a critical role in KIT signaling by regulating its cellular transport from early to late endosomes in hematopoietic cells. PLoS One (2014) 0.76
Prognostic Significance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis. PLoS One (2016) 0.76
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia. Oncotarget (2016) 0.75
Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia. Stem Cells Int (2016) 0.75
Class III Receptor Tyrosine Kinases in Acute Leukemia - Biological Functions and Modern Laboratory Analysis. Biomark Insights (2015) 0.75